OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations

OrthoPediatrics (Nasdaq: KIDS) announced the full commercial launch of its 3P™ Pediatric Plating Platform® Hip System in the United States after a limited launch that included more than 350 surgical implantations.

Rhea-AI Summary

OrthoPediatrics (Nasdaq: KIDS) announced the full commercial launch of its 3P™ Pediatric Plating Platform® Hip System in the United States after a limited launch that included more than 350 surgical implantations. The pediatric-specific system targets proximal femur trauma and deformity correction.

The 3P Hip System, the first product in the broader Pediatric Plating Platform portfolio, offers advanced implant and instrumentation technologies designed to enhance fixation options, streamline surgical workflow, and support procedures across Infant, Child, and Adolescent patient groups. According to OrthoPediatrics, this launch is a key milestone for its Trauma & Deformity business and establishes the foundation for additional plating systems intended to expand treatment options for pediatric orthopedic surgeons worldwide.

Positive

• Over 350 surgical implantations completed during limited launch
• Full U.S. commercial launch of 3P Pediatric Plating Platform Hip System
• Pediatric-specific design with Infant, Child, and Adolescent configurations
• Expanded plating portfolio foundation with planned additional 3P systems

Negative

• None.

Argus Aug 25 session

-2.35% close to close Open Argus

Details

News Market Reaction – KIDS

On Aug 25, the day this news came out, KIDS closed 2.35% below the previous close.

Data tracked by StockTitan Argus for the Aug 25 session.

Key Figures

Surgical implantations: over 350 implantations

Surgical implantations

over 350 implantations

Limited launch period for the 3P Hip System

Historical Context

5 past events · Latest: Aug 04

5 events

1. Aug 04

   2Q26 earnings report

   24h Move

   +6.8%

   Revenue growth, raised guidance, margin expansion, and record adjusted EBITDA

2. Jul 29

   Growth conference participation

   24h Move

   +0.6%

   Fireside chat participation at Canaccord Genuity growth conference

3. Jul 21

   Earnings date announcement

   24h Move

   -1.2%

   Scheduled second-quarter results release and conference call

4. Jun 24

   Distribution agreement

   24h Move

   +4.2%

   Exclusive OSSIO distribution agreement for pediatric fixation implants

5. May 26

   Healthcare conference participation

   24h Move

   -2.0%

   Fireside chat participation at Goldman Sachs healthcare conference

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

locking proximal femur plates, beam screw constructs

2 terms

locking proximal femur plates technical

"The comprehensive system includes Locking Proximal Femur Plates and Beam Screw constructs"

Metal surgical implants shaped like a plate that attach along the upper part of the thigh bone (proximal femur) and lock to screws to hold fractured bone pieces in place while they heal. They work like a rigid scaffolding with screw holes that accept threaded screws so the screws and plate act as one stable unit, which matters to investors because regulatory clearances, manufacturing quality, and implant demand affect device makers’ sales and liability exposure.

beam screw constructs technical

"Locking Proximal Femur Plates and Beam Screw constructs available in Infant, Child"

A beam screw construct is a type of spinal fixation assembly in which screws are anchored into vertebrae and linked by a longitudinal rod or beam to hold the spine in a fixed position. Think of it like scaffolding for the spine: the screws are anchor points and the beam keeps segments aligned while bone heals or fusion takes place. It matters to investors because such implants are a distinct class of medical devices with implications for surgical demand, product approvals, reimbursement, and device company revenues.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Successful Limited Launch Demonstrates Demand for Innovative Pediatric-Specific Hip Plating Technology

WARSAW, Ind., Aug. 25, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the full commercial launch of its 3P™ Pediatric Plating Platform^® Hip System.

Following a highly successful limited launch period that resulted in over 350 surgical implantations, the system is now broadly available to pediatric orthopedic surgeons throughout the United States. The 3P Hip System is the first system within the Company's broader Pediatric Plating Platform portfolio and represents a significant advancement in trauma and deformity correction.

"The response to the 3P Hip System during the limited launch period exceeded our expectations," said Joe Hauser, President of Trauma & Deformity and OPSB at OrthoPediatrics. "With over 350 surgical implantations completed prior to full commercialization, surgeons have validated both the clinical utility of the system and the need for continued innovation in plating technologies. This achievement reflects years of collaboration with leading pediatric orthopedic surgeons and our dedicated development team, and we're excited to now make the system broadly available to customers nationwide."

The 3P Pediatric Plating Platform Hip System was designed to modernize plating through advanced implant and instrumentation technologies that provide enhanced fixation options, streamlined workflow, and broad procedural versatility. The comprehensive system includes Locking Proximal Femur Plates and Beam Screw constructs available in Infant, Child, and Adolescent configurations for the treatment of proximal femur trauma and deformities.

The 3P Hip System is the first of several planned Pediatric Plating Platform systems expected to transform the Company's plating portfolio and expand treatment options for pediatric orthopedic surgeons worldwide.

David Bailey, President and Chief Executive Officer of OrthoPediatrics, commented, "The full commercial launch of the 3P Pediatric Plating Platform Hip System is an important milestone for OrthoPediatrics and our Trauma & Deformity business. The success of the limited launch validates both the strength of the product and the demand for continued innovation in pediatric orthopedics. As the first system within our broader Pediatric Plating Platform family, 3P Hip establishes the foundation for what we believe will become the most comprehensive and technologically advanced plating portfolio in pediatric orthopedics."

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 90 systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 75 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.

Investor Contact
Philip Taylor
Gilmartin Group
philip@gilmartinir.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did OrthoPediatrics (KIDS) announce about the 3P Pediatric Plating Platform Hip System on August 25, 2026?

OrthoPediatrics announced the full commercial launch of its 3P Pediatric Plating Platform Hip System in the United States. According to OrthoPediatrics, this follows a limited launch with more than 350 surgical implantations and marks a major milestone for its Trauma & Deformity business.

How many 3P Hip System implantations occurred before full commercialization of OrthoPediatrics (KIDS) product?

More than 350 surgical implantations were performed during the limited launch phase of the 3P Hip System. According to OrthoPediatrics, this early clinical use helped validate the system’s utility and demonstrated demand for innovative pediatric-specific hip plating technologies.

What patient groups does the OrthoPediatrics (KIDS) 3P Pediatric Plating Platform Hip System serve?

The 3P Hip System serves Infant, Child, and Adolescent patient groups requiring proximal femur trauma and deformity treatment. According to OrthoPediatrics, it offers Locking Proximal Femur Plates and Beam Screw constructs tailored to these age ranges to support pediatric-specific surgical needs.

How is the OrthoPediatrics (KIDS) 3P Hip System designed to improve pediatric hip surgery?

The 3P Hip System is designed to modernize plating through advanced implant and instrumentation technologies. According to OrthoPediatrics, it aims to provide enhanced fixation options, streamlined surgical workflow, and broad procedural versatility for pediatric orthopedic surgeons treating proximal femur conditions.

Is the OrthoPediatrics (KIDS) 3P Hip System part of a larger plating portfolio strategy?

Yes, the 3P Hip System is the first system in OrthoPediatrics’ broader Pediatric Plating Platform portfolio. According to OrthoPediatrics, it establishes a foundation for additional planned systems intended to create a comprehensive and technologically advanced pediatric plating portfolio.

Where is the OrthoPediatrics (KIDS) 3P Pediatric Plating Platform Hip System currently available?

The 3P Pediatric Plating Platform Hip System is now broadly available to pediatric orthopedic surgeons throughout the United States. According to OrthoPediatrics, this follows a successful limited launch and represents full commercial availability nationwide for its trauma and deformity applications.